Orthofix International (OFIX) Reports Prelim Q3 Net Sales of $114M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results
October 11, 2022 6:05 AM EDTThird quarter net sales of $114 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year Global Orthopedics net sales growth of 19% on a constant currency basis driven by commercial channel investments Biologics net sales growth of 8% driven by new product introductions Bone Growth Therapies net sales growth of 3% driven by the commercial roll-out of AccelStim Bone Healing Therapy Announced agreement to merge with SeaSpine Holdings Corporation (NASDAQ: SPNE or "SeaSpine"), creating a leading global spine and orthopedics... More
